Bank of Montreal Can Sells 3,162 Shares of Option Care Health, Inc. $OPCH

Bank of Montreal Can decreased its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 13.8% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,816 shares of the company’s stock after selling 3,162 shares during the quarter. Bank of Montreal Can’s holdings in Option Care Health were worth $644,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Fuller & Thaler Asset Management Inc. boosted its holdings in Option Care Health by 30.8% in the first quarter. Fuller & Thaler Asset Management Inc. now owns 4,204,481 shares of the company’s stock worth $146,947,000 after purchasing an additional 989,048 shares in the last quarter. Durable Capital Partners LP acquired a new stake in shares of Option Care Health in the first quarter worth about $122,905,000. Charles Schwab Investment Management Inc. boosted its stake in shares of Option Care Health by 4.0% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 2,609,705 shares of the company’s stock worth $91,209,000 after acquiring an additional 99,574 shares in the last quarter. Jennison Associates LLC increased its holdings in shares of Option Care Health by 145.6% during the 2nd quarter. Jennison Associates LLC now owns 2,138,248 shares of the company’s stock valued at $69,450,000 after acquiring an additional 1,267,660 shares during the last quarter. Finally, Nuveen LLC acquired a new position in shares of Option Care Health during the 1st quarter valued at about $70,965,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on OPCH shares. Weiss Ratings restated a “hold (c-)” rating on shares of Option Care Health in a report on Thursday. JMP Securities set a $36.00 price objective on shares of Option Care Health in a research note on Friday, October 31st. Citigroup reiterated an “outperform” rating on shares of Option Care Health in a research note on Friday, October 31st. Cowen assumed coverage on shares of Option Care Health in a report on Thursday, October 2nd. They issued a “hold” rating on the stock. Finally, Barrington Research restated an “outperform” rating and set a $38.00 price target on shares of Option Care Health in a report on Friday, October 31st. Nine investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $35.67.

Option Care Health Price Performance

Shares of Option Care Health stock opened at $28.41 on Monday. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. The company has a market cap of $4.51 billion, a PE ratio of 22.73, a price-to-earnings-growth ratio of 1.74 and a beta of 0.88. The firm has a fifty day moving average price of $27.77 and a two-hundred day moving average price of $29.58. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53.

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. bought 38,000 shares of Option Care Health stock in a transaction that occurred on Monday, November 3rd. The stock was purchased at an average cost of $25.98 per share, with a total value of $987,240.00. Following the completion of the transaction, the director directly owned 413,390 shares in the company, valued at $10,739,872.20. This trade represents a 10.12% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Norman L. Wright acquired 3,411 shares of the company’s stock in a transaction dated Tuesday, September 9th. The stock was acquired at an average price of $29.31 per share, with a total value of $99,976.41. Following the purchase, the director owned 15,501 shares in the company, valued at approximately $454,334.31. This represents a 28.21% increase in their position. The SEC filing for this purchase provides additional information. Insiders bought a total of 97,411 shares of company stock valued at $2,614,816 over the last ninety days. 0.64% of the stock is owned by company insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.